×
About 188 results

ALLMedicine™ Recurrent Bladder Cancer Center

Research & Reviews  91 results

Recurrent bladder cancer in aging societies: Importance of major histocompatibility com...
https://doi.org/10.1002/ijc.33359
International Journal of Cancer; Wieczorek E, Garstka MA

Oct 26th, 2020 - Aging is associated with an insufficient immune response that may lead to the initiation and progression of various malignancies. Bladder cancer (BC), prevalent in elderly patients, predominantly presents as recurrent nonmuscle invasive BC that re...

Recurrent Bladder Cancer in a Teenage Male.
https://doi.org/10.1016/j.urology.2020.04.031
Urology Peard L, Stark T et. al.

Apr 25th, 2020 - Urothelial cell carcinoma of the bladder is exceedingly rare in pediatric patients. Based on current literature, bladder cancer in this population is thought to be low-grade, noninvasive, and unlikely to recur, suggesting significant biologic diff...

S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
https://clinicaltrials.gov/ct2/show/NCT00445601

Jan 17th, 2020 - OBJECTIVES: Primary Compare the efficacy of a single intravesical instillation of gemcitabine hydrochloride vs placebo immediately after transurethral resection of the bladder tumor (TURBT) in preventing recurrence at 2 years in patients with grad...

Mycobacterium bovis prosthetic joint infection following intravesical instillation of B...
https://doi.org/10.1136/bcr-2019-231830
BMJ Case Reports; Patel A, Elzweig J

Dec 20th, 2019 - A 91-year-old man with a history of intravesicular BCG therapy for recurrent bladder cancer and bilateral total hip arthroplasty (THA) presented with left hip pain. He was noted to have a fluid collection over the left lateral hip and hip X-ray sh...

Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
https://clinicaltrials.gov/ct2/show/NCT03715660

Nov 20th, 2019 - The primary objective of this prospective, single-centre study is to establish the clinical performance characteristics of Xpert Bladder Cancer Monitor on the GeneXpert Instrument Systems in comparison to the methods currently used at the site for...

see more →

Clinicaltrials.gov  95 results

Recurrent bladder cancer in aging societies: Importance of major histocompatibility com...
https://doi.org/10.1002/ijc.33359
International Journal of Cancer; Wieczorek E, Garstka MA

Oct 26th, 2020 - Aging is associated with an insufficient immune response that may lead to the initiation and progression of various malignancies. Bladder cancer (BC), prevalent in elderly patients, predominantly presents as recurrent nonmuscle invasive BC that re...

Recurrent Bladder Cancer in a Teenage Male.
https://doi.org/10.1016/j.urology.2020.04.031
Urology Peard L, Stark T et. al.

Apr 25th, 2020 - Urothelial cell carcinoma of the bladder is exceedingly rare in pediatric patients. Based on current literature, bladder cancer in this population is thought to be low-grade, noninvasive, and unlikely to recur, suggesting significant biologic diff...

S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
https://clinicaltrials.gov/ct2/show/NCT00445601

Jan 17th, 2020 - OBJECTIVES: Primary Compare the efficacy of a single intravesical instillation of gemcitabine hydrochloride vs placebo immediately after transurethral resection of the bladder tumor (TURBT) in preventing recurrence at 2 years in patients with grad...

Mycobacterium bovis prosthetic joint infection following intravesical instillation of B...
https://doi.org/10.1136/bcr-2019-231830
BMJ Case Reports; Patel A, Elzweig J

Dec 20th, 2019 - A 91-year-old man with a history of intravesicular BCG therapy for recurrent bladder cancer and bilateral total hip arthroplasty (THA) presented with left hip pain. He was noted to have a fluid collection over the left lateral hip and hip X-ray sh...

Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
https://clinicaltrials.gov/ct2/show/NCT03715660

Nov 20th, 2019 - The primary objective of this prospective, single-centre study is to establish the clinical performance characteristics of Xpert Bladder Cancer Monitor on the GeneXpert Instrument Systems in comparison to the methods currently used at the site for...

see more →

News  2 results

Active Surveillance OK For Non-Muscle Invasive Bladder Cancer
https://www.medpagetoday.com/hematologyoncology/othercancers/70930

Feb 3rd, 2018 - Action Points Note that this observational study suggests that, for certain individuals with low-grade recurrent bladder cancer, active surveillance may be a viable alternative to transurethral resection of bladder tumor. The study did not take in...

Urine Test Speeds Detection of Bladder Cancer Recurrence
https://www.medpagetoday.com/hematologyoncology/othercancers/2506

Jan 18th, 2006 - Action Points Note that the BladderChek test for the protein NMP22 is an office procedure that yields results within an hour. In this study, the test, in combination with cystoscopy, detected 99% of recurrent bladder cancers, significantly better ...

see more →